Zdenek Skrott

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum Stress

Hodgkin Lymphoma

Palliative Care

Multiple Myeloma

Top Venues

International journal of molecular sciences

Cell death & disease

Cell death and differentiation

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Tereza Buchtova, David Lukac, Zdenek Skrott, Katarina Chroma, Jiri Bartek, Martin Mistrik
Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics. International journal of molecular sciences 24 (3) (2023)
Tereza Buchtova, David Lukac, Zdenek Skrott, Katarina Chroma, Jiri Bartek, Martin Mistrik
Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics. International journal of molecular sciences 24 (3) (2023)
Tereza Buchtova, David Lukac, Zdenek Skrott, Katarina Chroma, Jiri Bartek, Martin Mistrik
Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics. International journal of molecular sciences 24 (3) (2023)
Dimitris C Kanellis, Asimina Zisi, Zdenek Skrott, Bennie Lemmens, Jaime A Espinoza, Martin Kosar, Andrea Björkman, Xuexin Li, Stefanos Arampatzis, Jirina Bartkova, Miguel Andújar-Sánchez, Oscar Fernandez-Capetillo, Martin Mistrik, Mikael S Lindström, Jiri Bartek
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell death and differentiation (2023)
Katarina Chroma, Zdenek Skrott, Jan Gursky, Jaroslav Bacovsky, Pavel Moudry, Tereza Buchtova, Martin Mistrik, Jiri Bartek
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment. Cell death & disease 13 (3) (2022)
Martin Mistrik, Zdenek Skrott, Petr Muller, Ales Panacek, Lucie Hochvaldova, Katarina Chroma, Tereza Buchtova, Veronika Vandova, Libor Kvítek, Jiri Bartek
Microthermal-induced subcellular-targeted protein damage in cells on plasmonic nanosilver-modified surfaces evokes a two-phase HSP-p97/VCP response. Nature communications 12 (1) (2021)